We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Top Sells

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$122M
2
SUI icon
Sun Communities
SUI
+$107M
3
SPG icon
Simon Property Group
SPG
+$104M
4
WPC icon
W.P. Carey
WPC
+$76.5M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$70.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
1201
Xencor
XNCR
$1.46B
$5K ﹤0.01%
222
– –
MORF
1202
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$5K ﹤0.01%
155
– –
AUTL
1203
Autolus Therapeutics
AUTL
$381M
$4K ﹤0.01%
575
– –
BCRX icon
1204
BioCryst Pharmaceuticals
BCRX
$2.43B
$4K ﹤0.01%
692
– –
ETNB
1205
DELISTED
89bio
ETNB
$4K ﹤0.01%
344
+157
+84% +$1.74K
INVA icon
1206
Innoviva
INVA
$1.59B
$4K ﹤0.01%
260
– –
MIRM icon
1207
Mirum Pharmaceuticals
MIRM
$6.61B
$4K ﹤0.01%
148
– –
MRVI icon
1208
Maravai LifeSciences
MRVI
$972M
$4K ﹤0.01%
490
– –
OCUL icon
1209
Ocular Therapeutix
OCUL
$1.85B
$4K ﹤0.01%
407
+145
+55% +$1.03K
RLAY icon
1210
Relay Therapeutics
RLAY
$4.03B
$4K ﹤0.01%
486
– –
SAGE
1211
DELISTED
Sage Therapeutics
SAGE
$4K ﹤0.01%
239
– –
SPRY icon
1212
ARS Pharmaceuticals
SPRY
$570M
$4K ﹤0.01%
367
– –
SRRK icon
1213
Scholar Rock
SRRK
$5.89B
$4K ﹤0.01%
208
– –
TARS icon
1214
Tarsus Pharmaceuticals
TARS
$2.53B
$4K ﹤0.01%
107
– –
VRNA
1215
DELISTED
Verona Pharma
VRNA
$4K ﹤0.01%
244
– –
DCPH
1216
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
272
– –
ARCT icon
1217
Arcturus Therapeutics
ARCT
$164M
$3K ﹤0.01%
90
– –
AUPH icon
1218
Aurinia Pharmaceuticals
AUPH
$1.95B
$3K ﹤0.01%
528
– –
BCYC
1219
Bicycle Therapeutics
BCYC
$271M
$3K ﹤0.01%
103
– –
BNS icon
1220
Scotiabank
BNS
$106B
$3K ﹤0.01%
50
– –
CABA icon
1221
Cabaletta Bio
CABA
$432M
$3K ﹤0.01%
175
– –
ELVN icon
1222
Enliven Therapeutics
ELVN
$3.76B
$3K ﹤0.01%
+152
New +$2.33K
EYPT icon
1223
EyePoint Inc
EYPT
$1.03B
$3K ﹤0.01%
144
– –
GRFS
1224
Grifois
GRFS
$5.59B
$3K ﹤0.01%
398
– –
HCM icon
1225
HUTCHMED
HCM
$1.97B
$3K ﹤0.01%
185
– –
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.